Log In
BCIQ
Print this Print this
 

CX1942

  Manage Alerts
Collapse Summary General Information
Company RespireRx Pharmaceuticals Inc.
DescriptionSecond-generation positive allosteric modulator (PAM) of the AMPA glutamate receptor
Molecular Target AMPA glutamate receptor (GRIA) (GLUR)
Mechanism of ActionAMPA receptor enhancer
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationRespiratory distress syndrome (RDS)
Indication DetailsTreat drug-induced respiratory depression; Treat respiratory depression
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$25.0M

$10.0M

$15.0M


 Deals Details
Get a free BioCentury trial today